VRN-13

N/A

Report date: 2023/09/14 13:35:27

NME

Base Information

Drug NameVRN-13

Drug Alias NameVRN-13

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet-derived growth factor receptor inhibitors

TargetsPlatelet-derived growth factor receptor

Therapy Area/IndicationsPulmonary Arterial Hypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVoronoi Inc

China Registration ClassN/A

Active CompaniesVoronoi Inc

Inactive CompaniesN/A

Active IndicationsPulmonary Arterial Hypertension

Inactive IndicationsN/A

ATC CodeN/A